Aripiprazole is named as a drug or biological intervention in 5 clinical trials in our China and USA trial registers, 2 of which are recruiting. Lead sponsors include Minerva Neurosciences (1), Xinyu Zhou (1) and Central South University (1). Registered phases: Phase 3, Phase 4, Not applicable, Phase 2 and Phase 1/2. Conditions studied include Major Depressive Disorder (MDD); Negative Symptoms of Schizophrenia; Rumination.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07565428 | Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications (ClinicalTrials.gov ↗) Negative Symptoms of Schizophrenia |
Phase 3 | Recruiting |
| NCT05814640 | Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) (ClinicalTrials.gov ↗) Depression, Sequestra |
Phase 1/2 | Recruiting |
| NCT07011693 | Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression๏ผSMART-I) Major Depressive Disorder (MDD) |
Phase 4 | Not yet open |
| NCT07703956 | Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults (ClinicalTrials.gov ↗) Schizophrenia |
Phase 2 | Not yet open |
| NCT06937476 | Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole (ClinicalTrials.gov ↗) Major Depressive Disorder (MDD), Rumination |
Not applicable | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Major Depressive Disorder (MDD) | 2 |
| Negative Symptoms of Schizophrenia | 1 |
| Rumination | 1 |
| Schizophrenia | 1 |
| Depression | 1 |
| Sequestra | 1 |
| Lead sponsor | Trials |
|---|---|
| Minerva Neurosciences | 1 |
| Xinyu Zhou | 1 |
| Central South University | 1 |
| Vigonvita Life Sciences | 1 |
| First Affiliated Hospital of Chongqing Medical University | 1 |
| Register | Aripiprazole trials |
|---|---|
| Clinical trials in China | 4 |
| Clinical trials in USA | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records โ it is not written from memory, and nothing here describes how Aripiprazole works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Aripiprazole (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.